For research use only. Not for therapeutic Use.
Mirogabalin (CAT: I000523) is a medication that belongs to the class of gabapentinoids, which are used for the management of neuropathic pain. It acts as a selective ligand for the α2δ subunit of voltage-gated calcium channels in the central nervous system, reducing the release of certain neurotransmitters involved in pain transmission. Mirogabalin has demonstrated efficacy in the treatment of various types of neuropathic pain, including diabetic peripheral neuropathy and postherpetic neuralgia. It offers an alternative treatment option for individuals who may not adequately respond to or tolerate other medications commonly used for neuropathic pain relief.
| Catalog Number | I000523 |
| CAS Number | 1138245-13-2 |
| Synonyms | DS-5565 |
| Molecular Formula | C12H19NO2 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | 10 mM in DMSO, Methanol: ≥ 35 mg/mL |
| Storage | -20°C |
| IUPAC Name | 2-[(1R,5S,6S)-6-(aminomethyl)-3-ethyl-6-bicyclo[3.2.0]hept-3-enyl]acetic acid |
| InChI | InChI=1S/C12H19NO2/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15)/t9-,10-,12-/m1/s1 |
| InChIKey | FTBQORVNHOIASH-CKYFFXLPSA-N |
| SMILES | CCC1=CC2C(C1)CC2(CC(=O)O)CN |
